In Vitro Toxicology Assays Market Size Projected to Reach $4.7 billion by 2034 | 10.1%

According to Straits Research, the global in vitro toxicology assays market size was valued at $2.0 billion in 2025 and is expected to grow from $2.2 billion in 2026 to $4.7 billion by 2034, registering a CAGR of 10.1% during the forecast period (2026–2034).

The in vitro toxicology assays market is segmented based on assay type, technology, application, end use, and region. Some of the insights provided in the report are highlighted below:

• The genotoxicity assays segment is expected to register a CAGR of 10.18% during the forecast period.
• North America is expected to lead the market during the forecast period, owing to rapid adoption of advanced in vitro assay technologies.
• Regulatory support from the US FDA and the Environmental Protection Agency for non-animal testing is accelerating the commercialization of in vitro toxicology assays.
• The US is expected to lead the North America market due to increasing outsourcing of toxicology studies to CROs.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision-makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.